-
4-(1,1-dioxo-1λ6,2-thiazinan-2-yl)(2H4)benzene-1-sulfonamide
-
ChemBase ID:
178027
-
Molecular Formular:
C10H14N2O4S2
-
Molecular Mass:
290.35916
-
Monoisotopic Mass:
290.03949894
-
SMILES and InChIs
SMILES:
c1c(ccc(c1)N1S(=O)(=O)CCCC1)S(=O)(=O)N
Canonical SMILES:
O=S1(=O)CCCCN1c1ccc(cc1)S(=O)(=O)N
InChI:
InChI=1S/C10H14N2O4S2/c11-18(15,16)10-5-3-9(4-6-10)12-7-1-2-8-17(12,13)14/h3-6H,1-2,7-8H2,(H2,11,15,16)
InChIKey:
HMHVCUVYZFYAJI-UHFFFAOYSA-N
-
Cite this record
CBID:178027 http://www.chembase.cn/molecule-178027.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
4-(1,1-dioxo-1λ6,2-thiazinan-2-yl)(2H4)benzene-1-sulfonamide
|
|
|
|
|
IUPAC Traditional name
|
|
4-(1,1-dioxo-1λ6,2-thiazinan-2-yl)(2H4)benzenesulfonamide
|
|
|
|
|
Synonyms
|
|
4-(Tetrahydro-1,1-dioxido-2H-1,2-thiazin-2-yl)benzenesulfonamide-d4
|
|
4-(Tetrahydro-2H-1,2-thiazin-2-yl)benzenesulfonamide-d4 S,S-Dioxide
|
|
2-(p-Sulfamoylphenyl)-tetrahydro-2H-1,2-thiazine-d4 1,1-Dioxide
|
|
Bayer A 168-d4
|
|
Conadil-d4
|
|
Contravul-d4
|
|
Elisal-d4
|
|
Ospolot-d4
|
|
Riker 594-d4
|
|
Sulphenyltame-d4
|
|
Sulphenytame-d4
|
|
Sulphthiame-d4
|
|
Sulthiam-d4
|
|
Sulthiamine-d4
|
|
Sultiam-d4
|
|
Sultiame-d4
|
|
Trolone-d4
|
|
p-(Tetrahydro-2H-1,2-thiazin-2-yl)benzenesulfonamide-d4 Dioxide
|
|
Sulthiame-d4
|
|
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
|
Data Source
|
Data ID
|
Price
|
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
10.5486555
|
H Acceptors
|
4
|
H Donor
|
1
|
LogD (pH = 5.5)
|
-0.26592493
|
LogD (pH = 7.4)
|
-0.2661946
|
Log P
|
-0.26592147
|
Molar Refractivity
|
67.4606 cm3
|
Polarizability
|
27.679077 Å3
|
Polar Surface Area
|
97.54 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
S789502
|
|
Labelled Sulthiame, a benzenesulfonamide derivative. Sulthiame acts as an inhibitor of the enzyme carbonic anhydrase. Sulthiame is used as an anticonvulsant in the treatment of benign and symptomatic focal epilepsy. |
PATENTS
PATENTS
PubChem Patent
Google Patent